Pharmacokinetics and Safety of Cefamandole in Infants and Children
AUTOR(ES)
Chang, Chia T.
RESUMO
Cefamandole, a new cephalosporin antibiotic, has greater activity against common pathogens, including Escherichia coli, Haemophilus influenzae, and Proteus (including indole-positive strains), than available cephalosporin drugs. We have evaluated the safety and pharmacokinetics of this drug in 30 infants and children. Blood levels and urinary excretion of the drug were similar to those previously found in adults. The only side effects were mild and transient elevation of serum glutamic oxalacetic transaminase in 12 patients and of blood urea nitrogen in 1 patient in whom serum creatinine remained normal and unchanged.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352566Documentos Relacionados
- Pharmacokinetics and Safety of Cefamandole in Newborn Infants
- Pharmacokinetics of Cefamandole in Infants and Children
- Phase I Safety and Pharmacokinetics Study of Micronized Atovaquone in Human Immunodeficiency Virus-Infected Infants and Children
- Pharmacokinetics of cefprozil in infants and children.
- Pharmacokinetics of Gatifloxacin in Infants and Children
